Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Bausch & Lomb, Inc. Recalls Several Lots of Murocel Lubricant Eye Drops
Bausch & Lomb, Inc. is recalling all lots of Murocel (methylcellulose) Lubricant Opthalmic Solution (USP, 1%). The following lot numbers are being recalled because these lots did not meet the manufacturer's quality standards and may not be sterile: Lot Numbers and Expiration Dates: LOT: 467061 EXP: 09-30-2011 LOT: 487551 EXP: 11-30-2011 LOT: 548051 EXP: 05-31-2012 LOT: 132171 EXP: 08-31-2012 LOT: 136571 EXP: 11-30-2012 LOT: 140181 EXP: 01-31-2013 Following this voluntary product recall, Bausch + Lomb will discontinue the Murocel product entirely. Murocel is an over-the-counter ophthalmic solution indicated for the temporary relief of burning and irritation due to dryness of the eye. Bausch + Lomb offers other products that address these eye symptoms. Murocel contains the active ingredient methylcellulose. Methylcellulose is also sold under other brand names. This recall alert only applies to the select lots of Murocel (methylcellulose) Lubricant Opthalmic Solution (USP, 1%). No other methylcellulose products were involved in this recall. To view the FDA notice about this recall, please visit: http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Event-Detail.cfm?action=detail&id=61964&w=06202012 and http://www.bausch.com/en/Our-Company/Recent-News/2011-Archive/murocel-recall
Learn More

Noven Pharmaceutical Recalls Several Lots of Daytrana Patches
Noven Pharmaceutical and Shire US Inc. has recalled several lots of Daytrana (methylphenidate) transdermal system patch 10 mg (1.1 mg/hr), 15 mg (1.6 mg/hr), 20 mg (2.2 mg/hr), and 30 mg (3.3 mg/hr). The following lot numbers have been recalled because the transdermal patches in these lots may be difficult to peel open for use: Daytrana (methylphenidate) transdermal patch, 10 mg (1.1 mg/hr): Lot number 41843 Daytrana (methylphenidate) transdermal patch, 15 mg (1.6 mg/hr): Lot number 43783 Daytrana (methylphenidate) transdermal patch, 20 mg (2.2 mg/hr): Lot numbers 49203 and 50265 Daytrana (methylphenidate) transdermal patch, 30 mg (3.3 mg/hr): Lot numbers 43008 and 48591 Daytrana contains the active ingredient methylphenidate and is commonly used in the treatment of attention deficit disorders. This recall alert only applies to the select lots of Daytrana (methylphenidate) transdermal system patch 10 mg (1.1 mg/hr), 15 mg (1.6 mg/hr), 20 mg (2.2 mg/hr), and 30 mg (3.3 mg/hr). No other methylphenidate products were involved in this recall. To view the FDA notice about this recall, please visit: http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Event-Detail.cfm?action=detail&id=61891&w=06202012
Learn More

Date Published Title Drug Source
2012-07-22 Bausch & Lomb, Inc. Recalls Several Lots of Murocel Lubricant Eye Drops Methylcellulose FDA
2012-07-22 Noven Pharmaceutical Recalls Several Lots of Daytrana Patches Methylphenidate FDA
2012-07-22 Endo Pharmaceuticals Recalls One Lot of Endocet Tablets, 10 mg/650 mg Acetaminophen with Oxycodone FDA
2012-07-22 Dermallogix Partners Recalls Single Lot of DermaZinc Spray, 0.25% zinc pyritione Dermazinc FDA
2012-07-20 Mylan Pharmaceuticals Inc Recalls Single Lot of Alprazolam Extended-release Tablets, 2 mg Alprazolam FDA
2012-07-20 Ortho-McNeil-Janssen Pharmaceuticals, Inc. Recalls Single Lot of Duragesic 25 mcg/h Fentanyl FDA
2012-07-20 Mallinckrodt Inc. Recalls Several Lots of Methylin Chewable Tablets (methylphenidate HCl) 2.5 mg, 5 mg and 10 mg Methylphenidate FDA
2012-07-19 Shionogi Inc. Recalls Single Lot of Nisoldipine Extended Release Tablets, 17mg Nisoldipine FDA
2012-07-19 Teva Pharmaceuticals Recalls Single Lot of Mefloquine Tablets, 250 mg Mefloquine FDA
2012-07-19 Lloyd Pharmaceutical Recalls Select Lots of Levothroid 50 mcg and 75 mcg Tablets Levothyroxine FDA
2012-07-19 Watson Laboratories Recalls Several Lots of Loxapine Capsules Loxapine FDA
2012-07-19 Ranbaxy Recalls Single Lot of Balnetar Therapeutic Tar Bath, Coal Tar 2.5% FDA
2012-07-19 TEVA Phamaceuticals Recalls Single Lot of Metoprolol Tartrate Tablets 50 mg Metoprolol FDA
2012-07-10 FDA Approves Safety Program to Reduce Risk of Opioid Pain Relievers Oxymorphone FDA
2012-07-10 FDA Approves Safety Program to Reduce Risk of Opioid Pain Relievers Methadone FDA
2012-07-05 Physicians Total Care Recalls Several Lots of Lipitor (Atorvastatin calcium) 40 mg Atorvastatin FDA
2012-07-05 Teva Pharmaceuticals Recalls Several Lots of Jolessa 0.15 mg/0.03 mg Levonorgestrel with Ethinylestradiol FDA
2012-07-05 Physicians Total Care, Inc Recalls Several Lots of Morphine Sulfate Extended Release and Immediate Release tablet, 30 mg Morphine FDA
2012-06-29 FDA Consumer Update: How Long Should You Take Osteoporosis Drugs? Ibandronate Sodium FDA
2012-06-26 FDA Warns Cefepime Needs Dosage Reduced in Patients with Poor Kidney Function Cefepime FDA